Literature DB >> 8124114

Mefloquine.

N J White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8124114      PMCID： PMC2539249          DOI： 10.1136/bmj.308.6924.286

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Mefloquine for multidrug-resistant malaria.

Authors:  C Luxemburger; F Nosten; F ter Kuiile; L Frejacques; T Chongsuphajaisiddhi; N J White
Journal:  Lancet       Date:  1991-11-16       Impact factor: 79.321

2.  Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions.

Authors:  J L Bem; L Kerr; D Stuerchler
Journal:  J Trop Med Hyg       Date:  1992-06

Review 3.  Prophylaxis against malaria for travellers from the United Kingdom. Malaria Reference Laboratory and the Ross Institute.

Authors:  D Bradley
Journal:  BMJ       Date:  1993-05-08

4.  Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.

Authors:  R Steffen; E Fuchs; J Schildknecht; U Naef; M Funk; P Schlagenhauf; P Phillips-Howard; C Nevill; D Stürchler
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

5.  Long-term malaria prophylaxis with weekly mefloquine.

Authors:  H O Lobel; M Miani; T Eng; K W Bernard; A W Hightower; C C Campbell
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321

Review 6.  Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; K L Goa
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

7.  Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria.

Authors:  S Looareesuwan; C Viravan; S Vanijanonta; P Wilairatana; P Suntharasamai; P Charoenlarp; K Arnold; D Kyle; C Canfield; K Webster
Journal:  Lancet       Date:  1992-04-04       Impact factor: 79.321

8.  High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria.

Authors:  F O ter Kuile; F Nosten; M Thieren; C Luxemburger; M D Edstein; T Chongsuphajaisiddhi; L Phaipun; H K Webster; N J White
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226
  8 in total
  5 in total

1.  Mefloquine: contraindicated in patients with mood, psychotic or seizure disorders.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

2.  Genetics of mefloquine resistance in the rodent malaria parasite Plasmodium chabaudi.

Authors:  Pedro V L Cravo; Jane M-R Carlton; Paul Hunt; Laura Bisoni; Rose Ann Padua; David Walliker
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

3.  Malaria prophylaxis. Toxicity of mefloquine is similar to that of other chemoprophylaxis.

Authors:  A Croft
Journal:  BMJ       Date:  1995-07-15

4.  Chemotherapy of drug-resistant malaria.

Authors:  K C Kain
Journal:  Can J Infect Dis       Date:  1996-01

Review 5.  Clinical features and mechanistic insights into drug repurposing for combating COVID-19.

Authors:  Purva Asrani; Keshav Tiwari; Mathew Suji Eapen; Kielan Darcy McAlinden; Greg Haug; Matt D Johansen; Philip M Hansbro; Katie L Flanagan; Md Imtaiyaz Hassan; Sukhwinder Singh Sohal
Journal:  Int J Biochem Cell Biol       Date:  2021-11-05       Impact factor: 5.652
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.